Followers | 35 |
Posts | 1847 |
Boards Moderated | 0 |
Alias Born | 08/24/2006 |
Tuesday, October 06, 2015 12:34:03 PM
2) Kenny Hill. It was a very good conversation and he gave me a very respectful amount of his time. We discussed his vision and plans for Victory and the opportunities Victory is positioned to take advantage of. I feel very good about Victory for the first time in more years than I can remember. Kenny understands the business and how to grow the company through acquisition. I think he definitely has the banking and investment banking relationships behind him to successfully complete a major acquisition that will allow Victory to move to NASDAQ or the NYSE, which is the plan and the path that management is on. They tried to do the Merge/Acquisition with Lucas Oil, but there were problems that came out in discovery and due diligence.....unfortunate, but it is a risk of business. I think we are fortunate we have a CEO with the experience he has so we did not get stuck in someone else's mess.
I have suffered through two Reverse splits from previous management, and my break-even is about $10 a share....I plan to bring that value much lower in the coming weeks.
For the first time, I feel Victory shareholders are in very good hands. Our valuation and our share price is very small, and I expect that to grow tremendously in the near term. I think we can't go wrong buying the stock down here when no one else is buying!
Recent VYEY News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 08:31:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:21:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 08:47:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 10:14:09 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 09/19/2023 01:56:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 04:53:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2023 01:20:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM